George W. Morriss - May 17, 2022 Form 4 Insider Report for Neuberger Berman High Yield Strategies Fund Inc. (NHS)

Role
Director
Signature
/s/ George W. Morriss by his Attorney-in-Fact, Jennifer R. Gonzalez
Stock symbol
NHS
Transactions as of
May 17, 2022
Transactions value $
$32,362
Form type
4
Date filed
5/19/2022, 09:56 PM
Previous filing
Jun 28, 2021
Next filing
Mar 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHS Common Stock Exercise of in-the-money or at-the-money derivative security $32.4K +3.76K +70.51% $8.60 9.1K May 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHS Transferable Subscription Rights (rights to buy) Exercise of in-the-money or at-the-money derivative security -5.29K -100% 0 May 17, 2022 Common Stock 3.76K Direct F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares acquired over time under a distribution reinvestment plan.
F2 Neuberger Berman High Yield Strategies Fund Inc. (the "Fund") issued transferable subscription rights ("Rights") to its common stockholders of record as of the close of business on April 19, 2022 (the "Record Date") entitling the holders of these Rights to purchase additional shares of common stock of the Fund (the "Common Stock"). The holders of Common Stock of record on the Record Date ("Record Date Stockholders") were entitled to subscribe for additional shares of Common Stock at a discount to the market price of the Common Stock. The Fund distributed to Record Date Stockholders one Right for each share of Common Stock held on the Record Date. The Rights entitle their holders to purchase one new share of Common Stock for every three Rights held (1 for 3).
F3 Record Date Stockholders who fully exercised their Rights were entitled to subscribe, subject to certain limitations and subject to allotment, for additional Common Stock which was not subscribed for by other Record Date Stockholders (the "Over-Subscription Privilege"). The reporting person fully exercised all Rights received and subscribed for additional shares of Common Stock pursuant to the Over-Subscription Privilege. Fractional shares of Common Stock were not issued. The subscription period commenced on the Record Date and expired on May 17, 2022.
F4 The final subscription price of $8.60 per share of Common Stock was determined based upon the terms of the offer. The Common Stock subscribed for will be issued after receipt of all stockholder payments.
F5 Includes shares acquired through the Over-Subscription Privilege.